362 related articles for article (PubMed ID: 38201283)
1. Epigenetic Regulation of Neuroinflammation in Alzheimer's Disease.
Ma Y; Wang W; Liu S; Qiao X; Xing Y; Zhou Q; Zhang Z
Cells; 2023 Dec; 13(1):. PubMed ID: 38201283
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulons in Alzheimer's disease.
Raval M; Mishra S; Tiwari AK
Prog Mol Biol Transl Sci; 2023; 198():185-247. PubMed ID: 37225321
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics in Alzheimer's disease: a focus on DNA modifications.
Coppieters N; Dragunow M
Curr Pharm Des; 2011; 17(31):3398-412. PubMed ID: 21902668
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
Nagu P; Parashar A; Behl T; Mehta V
J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
[TBL] [Abstract][Full Text] [Related]
5. Glial Cell-Mediated Neuroinflammation in Alzheimer's Disease.
Al-Ghraiybah NF; Wang J; Alkhalifa AE; Roberts AB; Raj R; Yang E; Kaddoumi A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142483
[TBL] [Abstract][Full Text] [Related]
6. Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation.
Chen Y; Yu Y
J Neuroinflammation; 2023 Jul; 20(1):165. PubMed ID: 37452321
[TBL] [Abstract][Full Text] [Related]
7. Role of Chemokines in the Development and Progression of Alzheimer's Disease.
Wojcieszak J; Kuczyńska K; Zawilska JB
J Mol Neurosci; 2022 Sep; 72(9):1929-1951. PubMed ID: 35821178
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer's Disease.
He C; Huang ZS; Yu CC; Wang HH; Zhou H; Kong LH
Curr Med Sci; 2020 Dec; 40(6):1022-1030. PubMed ID: 33428129
[TBL] [Abstract][Full Text] [Related]
9. Neuroepigenetics and Alzheimer's Disease: An Update.
Zusso M; Barbierato M; Facci L; Skaper SD; Giusti P
J Alzheimers Dis; 2018; 64(3):671-688. PubMed ID: 29991138
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Changes in Alzheimer's Disease: DNA Methylation and Histone Modification.
De Plano LM; Saitta A; Oddo S; Caccamo A
Cells; 2024 Apr; 13(8):. PubMed ID: 38667333
[TBL] [Abstract][Full Text] [Related]
11. Microglia in the Neuroinflammatory Pathogenesis of Alzheimer's Disease and Related Therapeutic Targets.
Cai Y; Liu J; Wang B; Sun M; Yang H
Front Immunol; 2022; 13():856376. PubMed ID: 35558075
[TBL] [Abstract][Full Text] [Related]
12. The engagement of microglia in tau-targeted immunotherapy in Alzheimer's disease.
Palova D; Turic Csokova N; Markova K; Kontsekova E; Kovacech B; Zilkova M
Gen Physiol Biophys; 2021 Nov; 40(6):463-478. PubMed ID: 34897021
[TBL] [Abstract][Full Text] [Related]
13. The effects of microglia-associated neuroinflammation on Alzheimer's disease.
Wang C; Zong S; Cui X; Wang X; Wu S; Wang L; Liu Y; Lu Z
Front Immunol; 2023; 14():1117172. PubMed ID: 36911732
[TBL] [Abstract][Full Text] [Related]
14. Methylprednisolone alleviates cognitive functions through the regulation of neuroinflammation in Alzheimer's disease.
Sun Y; Li J; A N; Li Z; Zhong W; Chen L; Liu S; Zhang B; Zhu Z; Li X
Front Immunol; 2023; 14():1192940. PubMed ID: 37197654
[TBL] [Abstract][Full Text] [Related]
15. Neuroinflammation as a Potential Therapeutic Target in Alzheimer's Disease.
Liu P; Wang Y; Sun Y; Peng G
Clin Interv Aging; 2022; 17():665-674. PubMed ID: 35520949
[TBL] [Abstract][Full Text] [Related]
16. Regulation of neuroinflammation in Alzheimer's disease via nanoparticle-loaded phytocompounds with anti-inflammatory and autophagy-inducing properties.
Nayak V; Patra S; Rout S; Jena AB; Sharma R; Pattanaik KP; Singh J; Pandey SS; Singh RP; Majhi S; Singh KR; Kerry RG
Phytomedicine; 2024 Jan; 122():155150. PubMed ID: 37944239
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic modification is linked to Alzheimer's disease: is it a maker or a marker?
Lee J; Ryu H
BMB Rep; 2010 Oct; 43(10):649-55. PubMed ID: 21034526
[TBL] [Abstract][Full Text] [Related]
18. Role of neurotoxicants in the pathogenesis of Alzheimer's disease: a mechanistic insight.
Nisa FY; Rahman MA; Hossen MA; Khan MF; Khan MAN; Majid M; Sultana F; Haque MA
Ann Med; 2021 Dec; 53(1):1476-1501. PubMed ID: 34433343
[TBL] [Abstract][Full Text] [Related]
19. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
Lantz MJ; Roberts AM; Delgado DD; Nichols RA
J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024
[TBL] [Abstract][Full Text] [Related]
20. The Role of Epigenetics in Neuroinflammatory-Driven Diseases.
Giallongo S; Longhitano L; Denaro S; D'Aprile S; Torrisi F; La Spina E; Giallongo C; Mannino G; Lo Furno D; Zappalà A; Giuffrida R; Parenti R; Li Volti G; Tibullo D; Vicario N
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
